193 related articles for article (PubMed ID: 20651007)
1. Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal.
Yang L; Li X; Ji Y; Kohan AB; Wang DQ; Howles PN; Hui DY; Lai J; Tso P
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1003-11. PubMed ID: 20651007
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
[TBL] [Abstract][Full Text] [Related]
3. Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats.
Kindel TL; Yang Q; Yoder SM; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G168-74. PubMed ID: 19056762
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
Mayer F; Gunawan AL; Tso P; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
[TBL] [Abstract][Full Text] [Related]
5. Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight.
Wang F; Yoder SM; Yang Q; Kohan AB; Kindel TL; Wang J; Tso P
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(10):G807-15. PubMed ID: 26336929
[TBL] [Abstract][Full Text] [Related]
6. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.
Moss CE; Marsh WJ; Parker HE; Ogunnowo-Bada E; Riches CH; Habib AM; Evans ML; Gribble FM; Reimann F
Diabetologia; 2012 Nov; 55(11):3094-103. PubMed ID: 22872212
[TBL] [Abstract][Full Text] [Related]
8. Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.
Lu WJ; Yang Q; Yang L; Lee D; D'Alessio D; Tso P
Lipids; 2012 Jun; 47(6):571-80. PubMed ID: 22297815
[TBL] [Abstract][Full Text] [Related]
9. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G622-30. PubMed ID: 24525020
[TBL] [Abstract][Full Text] [Related]
10. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
11. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
12. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose.
Lu WJ; Yang Q; Sun W; Woods SC; D'Alessio D; Tso P
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1130-8. PubMed ID: 18372393
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats.
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G476-85. PubMed ID: 20522638
[TBL] [Abstract][Full Text] [Related]
15. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats.
Gniuli D; Calcagno A; Dalla Libera L; Calvani R; Leccesi L; Caristo ME; Vettor R; Castagneto M; Ghirlanda G; Mingrone G
Diabetologia; 2010 Oct; 53(10):2233-40. PubMed ID: 20585935
[TBL] [Abstract][Full Text] [Related]
16. Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells.
Psichas A; Glass LL; Sharp SJ; Reimann F; Gribble FM
Br J Pharmacol; 2016 Mar; 173(5):888-98. PubMed ID: 26661062
[TBL] [Abstract][Full Text] [Related]
17. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
18. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
Damholt AB; Buchan AM; Kofod H
Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
[TBL] [Abstract][Full Text] [Related]
20. The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.
Kindel TL; Yoder SM; D'Alessio DA; Tso P
Obes Surg; 2010 Jun; 20(6):768-75. PubMed ID: 20177809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
